IP Library Granted Patent US 7,014,612
Granted Patent B2
US 7,014,612 · App. 10/294,352 · Granted Mar 21, 2006

Method for diagnosis of

Assignee: Photonic Biosystems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,014,612
App. No.
10/294,352
Granted
Mar 21, 2006
Kind
B2
Abstract

A rapid, non-invasive breath-test method and device for diagnosing the presence or absence of H. pylori in a subject without administration of isotopic tracers is described. The device consists of a highly sensitive colorimetric ammonia sensor placed in contact with sampled subject breath. The sensor is measured using appropriate reflection spectroscopy instrumentation. The breath-test method consists of measuring a basal ammonia level with the device, administering non-isotopic urea and continuing measurement of the ammonia content in a plurality of consecutive breaths. Diagnostic differences in breath ammonia are identified between H. pylori infected and uninfected individuals.

Claims (30)

1. A method for detecting the presence or absence of H. pylori infection in an individual comprising:

a) exposing at least one ammonia sensitive sensor to expiration of an individual, wherein where more than one sensor is exposed, the sensors are exposed to identical samples of respiration;

b) deriving, based on response of the at least one sensor to the exposure, a basal ammonia measure of expired ammonia over a basal measurement period; and

c) comparing the basal ammonia measure against a normative value that reflects at least one of a H. pylori positive population measure and a H. pylori negative population measure, wherein the H. pylori status of the individual is determined.

2. The method of claim 1 , further comprising:

a) administering a H. pylori urease enzyme substrate following determination of the basal ammonia measure;

b) deriving a post-substrate ammonia measure of expired ammonia over a post-urea measurement period of about 10 minutes to about 90 minutes after the administration of the substrate; and

c) comparing at least one measure of expired ammonia selected from the group consisting of the absolute measure of the post-substrate period, the absolute difference between the measures of the basal period and post-substrate period, the relative change between the measures of the basal period and post-substrate period, and, the rate of change in expired ammonia measures during the post-substrate period, against a normative value that reflects at least one of a H. pylori positive and a H. pylori negative population measures, wherein the H. pylori status of the individual is determined.

3. The method of claim 2 , further comprising:

a) administering an agent intended to increase expired ammonia either coincident or subsequent to administration of the H. pylori urease enzyme substrate;

b) deriving a post-substrate and post-agent ammonia measure of expired ammonia over a post-agent measurement period of about 10 minutes to about 90 minutes after ingestion of the substrate and agent; and

c) comparing at least one measure of expired ammonia selected from the group consisting of the absolute measure of the post-agent period, the absolute difference between the measure of the basal period, post-urea period and post-agent period, the relative change between the measures of the basal period, post-urea period, and post-agent period, and, the rate of change in expired ammonia measures during the basal period, post-substrate period, and post-agent period, against a normative value that reflects at least one of a H. pylori positive and H. pylori negative population values, wherein the H. pylori status of the individual is determined.

4. The method of claim 3 , wherein the agent intended to increase expired ammonia either coincident or subsequent to administration of the H. pylori urease enzyme substrate is an antacid.

5. The method of claim 3 , wherein the agent intended to increase expired ammonia either coincident or subsequent to administration of the H. pylori urease enzyme substrate comprises about 2 g aluminum hydroxide and about 2 g magnesium hydroxide.

6. The method of claim 1 , 2 or 3 , wherein the individual undergoing testing fasts for at least 8 hours before initiation of the method.

7. The method of claim 1 , wherein the at least one ammonia sensitive sensor has a sensitivity to ammonia in the range of about 0.05 ppm to about 5 ppm.

8. The method of claim 1 , wherein the ammonia sensitive sensor is an optical sensor for expired ammonia, comprising:

a solid substrate; and

an ammonia sensitive indicator dye having measurable spectral characteristics immobilized in or on the solid substrate so that exposure of the dye to expired ammonia causes a change in the spectral characteristics of the ammonia-sensitive indicator dye.

9. The method of claim 8 , wherein the substrate is polytetrafluorethylene.

10. The method of claim 8 , wherein the indicator dye is a non-water soluble pH indicator dye.

11. The method of claim 8 , wherein the substrate is an ammonia permeable solid-phase film.

12. The method of claim 10 , wherein the indicator dye is a weak acid compound that undergoes changes in its absorption spectra upon acid/base dissociation.

13. The method of claim 12 wherein the weak acid compound is selected from the group consisting of bromocresol green and bromophenol purple.

14. The method of claim 8 , wherein the substrate is a gas permeable hydrophobic polymer.

15. The method of claim 14 , wherein the hydrophobic polymer is a substituted ethylenic polymer.

16. The method of claim 8 , wherein the substrate is porous.

17. The method of claim 1 , wherein comparing the basal ammonia measure in c) comprises comparing a basal ammonia measure selected from the group consisting of: an absolute value measurement; a rate of change measurement; and combinations thereof.

18. The method of claim 1 , wherein where more than one sensor is exposed, the sensors are exposed to the identical respiration samples within a single chamber.

19. The method of claim 1 , wherein where more than one sensor is exposed, the sensors are exposed to identical respiration samples in different chambers.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2003
From: HUBBARD, TODD W.; PUTNAM, DAVID L.
To: PHOTONIC BIOSYSTEMS, INC.
Reel/Frame 014732/0665 →
Continuity (2)
Provisional Application 6033127500 · Nov 13, 2001
Related Publication 20040077965A1 · Apr 22, 2004